Given the mechanism of action of SGLT-2 inhibitors to reduce insulin resistance through decreasing glucose and sodium reabsorption, SGLT-2 inhibitors may play a significant role in reversing advanced liver fibrosis. Here, SLC5A2 is linked to Insulin resistance.